Daxor Corporation Insider Trading
DXR
Insiders bought 27K on the open market and sold nothing.
Get an email when DXR's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 19 | Robert J Michel Chief Financial Officer | Bought | 1,000 | $8.03 | 8K | 3.0% | Form 4 |
| Apr 8 | Michael Richard Feldschuh Chief Executive Officer | Bought | 1,000 | $9.07 | 9K | 0.5% | Form 4 |
| Mar 31 | Robert J Michel Chief Financial Officer | Bought | 1,000 | $9.90 | 10K | 5.0% | Form 4 |
| Mar 20 | John Jefferies Chief Medical Officer | Bought 2 parts | 5,941 | — | — | 34% | Form 4 |
| Dec 9, 2025 | Robert J Michel Chief Financial Officer | Bought | 3,000 | — | — | 18% | Form 4 |
| Dec 9, 2025 | Jonathan Adam Feldschuh Chief Scientific Officer | Bought | 18,000 | — | — | 50% | Form 4 |
| Nov 12, 2025 | John Jefferies Chief Medical Officer | Bought | 2,344 | — | — | 15% | Form 4 |
| Apr 4, 2025 | Michael Richard Feldschuh Chief Executive Officer | Bought | 2,063 | $7.89 | 16K | 1.0% | Form 4 |
| Mar 10, 2025 | Robert J Michel Chief Financial Officer | Bought | 1,000 | $8.00 | 8K | 6.2% | Form 4 |
| Mar 10, 2025 | Michael Richard Feldschuh Chief Executive Officer | Bought | 3,360 | $7.68 | 26K | 1.6% | Form 4 |
| Dec 6, 2024 | Jonathan Adam Feldschuh Chief Scientific Officer | Bought | 32,000 | — | — | 819% | Form 4 |
| Dec 6, 2024 | Michael Richard Feldschuh Chief Executive Officer | Bought | 45,000 | — | — | 28% | Form 4 |
- Nov 19Robert J MichelChief Financial Officer · bought 1,000 at $8.038K3.0% of stake
- Apr 8Michael Richard FeldschuhChief Executive Officer · bought 1,000 at $9.079K0.5% of stake
- Mar 31Robert J MichelChief Financial Officer · bought 1,000 at $9.9010K5.0% of stake
- Mar 20John JefferiesChief Medical Officer · bought 5,941—34% of stake
- Dec 9, 2025Robert J MichelChief Financial Officer · bought 3,000—18% of stake
- Dec 9, 2025Jonathan Adam FeldschuhChief Scientific Officer · bought 18,000—50% of stake
- Nov 12, 2025John JefferiesChief Medical Officer · bought 2,344—15% of stake
- Apr 4, 2025Michael Richard FeldschuhChief Executive Officer · bought 2,063 at $7.8916K1.0% of stake
- Mar 10, 2025Robert J MichelChief Financial Officer · bought 1,000 at $8.008K6.2% of stake
- Mar 10, 2025Michael Richard FeldschuhChief Executive Officer · bought 3,360 at $7.6826K1.6% of stake
- Dec 6, 2024Jonathan Adam FeldschuhChief Scientific Officer · bought 32,000—819% of stake
- Dec 6, 2024Michael Richard FeldschuhChief Executive Officer · bought 45,000—28% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Spot a number that looks wrong? Check it in DXR's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing DXR
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.